Allergan Plc Stock Current Liabilities
Allergan Plc fundamentals help investors to digest information that contributes to Allergan Plc's financial success or failures. It also enables traders to predict the movement of Allergan Stock. The fundamental analysis module provides a way to measure Allergan Plc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Allergan Plc stock.
Allergan |
Allergan Plc Company Current Liabilities Analysis
Allergan Plc's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Allergan Plc Current Liabilities | 8.29 B |
Most of Allergan Plc's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Allergan Plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
CompetitionIn accordance with the recently published financial statements, Allergan Plc has a Current Liabilities of 8.29 B. This is 373.21% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The current liabilities for all United States stocks is 4.93% lower than that of the firm.
Allergan Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Allergan Plc's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Allergan Plc could also be used in its relative valuation, which is a method of valuing Allergan Plc by comparing valuation metrics of similar companies.Allergan Plc is currently under evaluation in current liabilities category among its peers.
Allergan Fundamentals
Return On Equity | -0.0913 | |||
Return On Asset | -0.0564 | |||
Profit Margin | (0) % | |||
Operating Margin | 6.84 % | |||
Current Valuation | 81.41 B | |||
Shares Outstanding | 328.1 M | |||
Shares Owned By Insiders | 0.16 % | |||
Shares Owned By Institutions | 98.25 % | |||
Number Of Shares Shorted | 15.01 M | |||
Price To Earning | 24.00 X | |||
Price To Book | 1.07 X | |||
Price To Sales | 3.95 X | |||
Revenue | 15.82 B | |||
Gross Profit | 13.65 B | |||
EBITDA | 7.11 B | |||
Net Income | (9.25 B) | |||
Cash And Equivalents | 4.56 B | |||
Cash Per Share | 13.88 X | |||
Total Debt | 23.08 B | |||
Debt To Equity | 39.40 % | |||
Current Ratio | 1.00 X | |||
Book Value Per Share | 161.90 X | |||
Cash Flow From Operations | 6.47 B | |||
Short Ratio | 3.22 X | |||
Earnings Per Share | (27.98) X | |||
Price To Earnings To Growth | 3.66 X | |||
Number Of Employees | 17.4 K | |||
Beta | 1.2 | |||
Market Capitalization | 63.66 B | |||
Total Asset | 135.58 B | |||
Retained Earnings | 1.02 B | |||
Working Capital | 287.1 M | |||
Current Asset | 8.58 B | |||
Current Liabilities | 8.29 B | |||
Z Score | 1.2 | |||
Last Dividend Paid | 0.74 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Allergan Stock
If you are still planning to invest in Allergan Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Allergan Plc's history and understand the potential risks before investing.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |